RIP
PFE icon

Reliant Investment Partners’s Pfizer PFE Stock Holding History

Reliant Investment Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$685K Buy
28,447
+200
+0.7% +$5.23K 0.47% 49
2026
Q1 		$793K Sell
28,247
-50
-0.2% -$1.33K 0.66% 38
2025
Q4 		$705K Sell
28,297
-763
-3% -$19.2K 0.55% 46
2025
Q3 		$795K Sell
29,060
-150
-0.5% -$3.7K 0.62% 38
2025
Q2 		$708K Buy
29,210
+1,198
+4% +$27.9K 0.62% 38
2025
Q1 		$710K Sell
28,012
-651
-2% -$17K 0.72% 30
2024
Q4 		$760K Buy
+28,663
New +$777K 0.67% 32

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Reliant Investment Partners's PFE Position: Q2 2026 in Review

Reliant Investment Partners increased its Pfizer (PFE) stake by 0.71% in Q2 2026, buying an estimated $5.23K and bringing the position to 28,447 shares worth $685K. The position accounts for 0.47% of the portfolio, ranked #49.

Reliant Investment Partners first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $795K in Q3 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Reliant Investment Partners held 28,447 shares of Pfizer worth $685K as of Q2 2026.
  • Reliant Investment Partners bought 200 Pfizer shares in Q2 2026, an estimated $5.23K.
  • Pfizer made up 0.47% of Reliant Investment Partners's portfolio in Q2 2026, its #49 holding.
  • Reliant Investment Partners first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Reliant Investment Partners's Pfizer position peaked at $795K in Q3 2025.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Reliant Investment Partners's 13F filing for Q2 2026, filed 11 Aug 2026.